Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Warmed versus room-temperature albumin bolus for hypotension in ICU patients
ACTRN12618001644257Phase 2Not yet recruiting
- Sponsor
- Flinders Medical Centre
- Start
- Feb 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of albumin (human) in hypotension and Shock (2 arms), sponsored by Flinders Medical Centre. Primary endpoint: Change in stroke volume. Planned start Feb 2019; status: not yet recruiting.
02
Drugs
albumin (human)
03
Conditions
hypotensionShock
Beyond the preview
Go deeper on ACTRN12618001644257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618001644257.